|
US2671750A
(en)
*
|
1950-09-19 |
1954-03-09 |
Merck & Co Inc |
Stable noncaking aqueous suspension of cortisone acetate and method of preparing the same
|
|
US3536074A
(en)
*
|
1968-03-29 |
1970-10-27 |
Alfred Aufhauser |
Oral administration of a pill,tablet or capsule
|
|
US3959457A
(en)
*
|
1970-06-05 |
1976-05-25 |
Temple University |
Microparticulate material and method of making such material
|
|
JPS4932056B1
(https=)
*
|
1970-12-22 |
1974-08-27 |
|
|
|
US4073943A
(en)
*
|
1974-09-11 |
1978-02-14 |
Apoteksvarucentralen Vitrum Ab |
Method of enhancing the administration of pharmalogically active agents
|
|
US4107288A
(en)
*
|
1974-09-18 |
1978-08-15 |
Pharmaceutical Society Of Victoria |
Injectable compositions, nanoparticles useful therein, and process of manufacturing same
|
|
US4001200A
(en)
*
|
1975-02-27 |
1977-01-04 |
Alza Corporation |
Novel polymerized, cross-linked, stromal-free hemoglobin
|
|
US4001401A
(en)
*
|
1975-02-02 |
1977-01-04 |
Alza Corporation |
Blood substitute and blood plasma expander comprising polyhemoglobin
|
|
US4053590A
(en)
*
|
1975-02-27 |
1977-10-11 |
Alza Corporation |
Compositions of matter comprising macromolecular hemoglobin
|
|
DK143689C
(da)
*
|
1975-03-20 |
1982-03-15 |
J Kreuter |
Fremgangsmaade til fremstilling af en adsorberet vaccine
|
|
US4226248A
(en)
*
|
1978-10-26 |
1980-10-07 |
Manoli Samir H |
Phonocephalographic device
|
|
US4344934A
(en)
*
|
1978-11-20 |
1982-08-17 |
American Home Products Corporation |
Therapeutic compositions with enhanced bioavailability
|
|
DE3013839A1
(de)
*
|
1979-04-13 |
1980-10-30 |
Freunt Ind Co Ltd |
Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
|
|
US4247406A
(en)
*
|
1979-04-23 |
1981-01-27 |
Widder Kenneth J |
Intravascularly-administrable, magnetically-localizable biodegradable carrier
|
|
US4316885A
(en)
*
|
1980-08-25 |
1982-02-23 |
Ayerst, Mckenna And Harrison, Inc. |
Acyl derivatives of rapamycin
|
|
US4534899A
(en)
*
|
1981-07-20 |
1985-08-13 |
Lipid Specialties, Inc. |
Synthetic phospholipid compounds
|
|
US4572203A
(en)
*
|
1983-01-27 |
1986-02-25 |
Feinstein Steven B |
Contact agents for ultrasonic imaging
|
|
US4718433A
(en)
*
|
1983-01-27 |
1988-01-12 |
Feinstein Steven B |
Contrast agents for ultrasonic imaging
|
|
US4725442A
(en)
*
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
|
US4671954A
(en)
*
|
1983-12-13 |
1987-06-09 |
University Of Florida |
Microspheres for incorporation of therapeutic substances and methods of preparation thereof
|
|
US4600531A
(en)
*
|
1984-06-27 |
1986-07-15 |
University Of Iowa Research Foundation |
Production of alpha-alpha cross-linked hemoglobins in high yield
|
|
US4598064A
(en)
*
|
1984-06-27 |
1986-07-01 |
University Of Iowa Research Foundation |
Alpha-alpha cross-linked hemoglobins
|
|
US4639364A
(en)
*
|
1984-11-14 |
1987-01-27 |
Mallinckrodt, Inc. |
Methods and compositions for enhancing magnetic resonance imaging
|
|
US4584130A
(en)
*
|
1985-03-29 |
1986-04-22 |
University Of Maryland |
Intramolecularly cross-linked hemoglobin and method of preparation
|
|
FR2608942B1
(fr)
*
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
|
|
US5006650A
(en)
*
|
1987-02-11 |
1991-04-09 |
The Upjohn Company |
Novel N-1 substituted beta-lactams as antibiotics
|
|
US5723147A
(en)
*
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
|
KR890700586A
(ko)
*
|
1987-02-27 |
1989-04-25 |
로버어트 에이 아마테이지 |
피리돈 카르복실산 또는 산유도체를 함유하는 항균제 베타-락탐
|
|
US5015737A
(en)
*
|
1987-07-22 |
1991-05-14 |
The Upjohn Company |
Therapeutically useful beta-lactams
|
|
US4844882A
(en)
*
|
1987-12-29 |
1989-07-04 |
Molecular Biosystems, Inc. |
Concentrated stabilized microbubble-type ultrasonic imaging agent
|
|
US4929446A
(en)
*
|
1988-04-19 |
1990-05-29 |
American Cyanamid Company |
Unit dosage form
|
|
US4951673A
(en)
*
|
1988-08-19 |
1990-08-28 |
Alliance Pharmaceutical Corp. |
Magnetic resonance imaging with perfluorocarbon hydrides
|
|
US5041292A
(en)
*
|
1988-08-31 |
1991-08-20 |
Theratech, Inc. |
Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
|
|
US5114703A
(en)
*
|
1989-05-30 |
1992-05-19 |
Alliance Pharmaceutical Corp. |
Percutaneous lymphography using particulate fluorocarbon emulsions
|
|
GB8914060D0
(en)
*
|
1989-06-19 |
1989-08-09 |
Wellcome Found |
Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
|
|
US5116599A
(en)
*
|
1989-07-31 |
1992-05-26 |
Johns Hopkins Univ. |
Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
|
|
FR2651680B1
(fr)
*
|
1989-09-14 |
1991-12-27 |
Medgenix Group Sa |
Nouveau procede de preparation de microparticules lipidiques.
|
|
JP2687245B2
(ja)
*
|
1989-09-29 |
1997-12-08 |
富士写真フイルム株式会社 |
磁気記録媒体の製造方法
|
|
US5250283A
(en)
*
|
1990-03-28 |
1993-10-05 |
Molecular Biosystems, Inc. |
Organic contrast agent analog and method of making same
|
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
CA2019719A1
(en)
*
|
1990-06-25 |
1991-12-25 |
William J. Thompson |
Mouthwash
|
|
US5059699A
(en)
*
|
1990-08-28 |
1991-10-22 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble derivatives of taxol
|
|
US5110606A
(en)
*
|
1990-11-13 |
1992-05-05 |
Affinity Biotech, Inc. |
Non-aqueous microemulsions for drug delivery
|
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
AU642066B2
(en)
*
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
|
US5143716A
(en)
*
|
1991-02-01 |
1992-09-01 |
Unger Evan C |
Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
|
|
US5416071A
(en)
*
|
1991-03-12 |
1995-05-16 |
Takeda Chemical Industries, Ltd. |
Water-soluble composition for sustained-release containing epo and hyaluronic acid
|
|
US5434143A
(en)
*
|
1991-05-10 |
1995-07-18 |
Boron Biologicals, Inc. |
Pharmaceutical compositions comprising phosphite-borane compounds
|
|
GB9111580D0
(en)
*
|
1991-05-30 |
1991-07-24 |
Wellcome Found |
Nucleoside derivative
|
|
US5442062A
(en)
*
|
1991-10-24 |
1995-08-15 |
The Upjohn Company |
Imidazole derivatives and pharmaceutical compositions containing the same
|
|
US5292650A
(en)
*
|
1991-10-29 |
1994-03-08 |
Eli Lilly And Company |
Preparation of hapalindole-related alkaloids from blue-green algae
|
|
ATE194767T1
(de)
*
|
1992-03-23 |
2000-08-15 |
Univ Georgetown |
In liposomen verkapseltes taxol und verwendungsverfahren
|
|
CA2086874E
(en)
*
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
|
AU660852B2
(en)
*
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
|
US5302401A
(en)
*
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
|
US5429824A
(en)
*
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
|
US5326552A
(en)
*
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
|
US5401492A
(en)
*
|
1992-12-17 |
1995-03-28 |
Sterling Winthrop, Inc. |
Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
|
|
US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
NZ262679A
(en)
*
|
1993-02-22 |
1997-08-22 |
Vivorx Pharmaceuticals Inc |
Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
|
|
US6749868B1
(en)
*
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5362478A
(en)
*
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6753006B1
(en)
*
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5395619A
(en)
*
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
US5264610A
(en)
*
|
1993-03-29 |
1993-11-23 |
Sterling Winthrop Inc. |
Iodinated aromatic propanedioates
|
|
TW406020B
(en)
*
|
1993-09-29 |
2000-09-21 |
Bristol Myers Squibb Co |
Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
|
|
US5766627A
(en)
*
|
1993-11-16 |
1998-06-16 |
Depotech |
Multivescular liposomes with controlled release of encapsulated biologically active substances
|
|
US5731334A
(en)
*
|
1994-01-11 |
1998-03-24 |
The Scripps Research Institute |
Method for treating cancer using taxoid onium salt prodrugs
|
|
IL112920A
(en)
*
|
1994-03-07 |
2003-04-10 |
Dow Chemical Co |
Composition comprising a dendritic polymer complexed with at least one unit of biological response modifier and a process for the preparation thereof
|
|
US5565478A
(en)
*
|
1994-03-14 |
1996-10-15 |
The United States Of America As Represented By The Department Of Health & Human Services |
Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
|
|
GB9405593D0
(en)
*
|
1994-03-22 |
1994-05-11 |
Zeneca Ltd |
Pharmaceutical compositions
|
|
US5731356A
(en)
*
|
1994-03-22 |
1998-03-24 |
Zeneca Limited |
Pharmaceutical compositions of propofol and edetate
|
|
TW384224B
(en)
*
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
|
US5718388A
(en)
*
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
|
US5543152A
(en)
*
|
1994-06-20 |
1996-08-06 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5626862A
(en)
*
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5628981A
(en)
*
|
1994-12-30 |
1997-05-13 |
Nano Systems L.L.C. |
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
|
|
US5593657A
(en)
*
|
1995-02-09 |
1997-01-14 |
Nanosystems L.L.C. |
Barium salt formulations stabilized by non-ionic and anionic stabilizers
|
|
US5622938A
(en)
*
|
1995-02-09 |
1997-04-22 |
Nano Systems L.L.C. |
Sugar base surfactant for nanocrystals
|
|
US5518738A
(en)
*
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
|
US5591456A
(en)
*
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
|
US5500204A
(en)
*
|
1995-02-10 |
1996-03-19 |
Eastman Kodak Company |
Nanoparticulate diagnostic dimers as x-ray contrast agents for blood pool and lymphatic system imaging
|
|
US5510118A
(en)
*
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5528328A
(en)
*
|
1995-02-21 |
1996-06-18 |
O'farrill; Dave |
Camera filter quick release adapter
|
|
US5718919A
(en)
*
|
1995-02-24 |
1998-02-17 |
Nanosystems L.L.C. |
Nanoparticles containing the R(-)enantiomer of ibuprofen
|
|
US5747001A
(en)
*
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
|
JP4484247B2
(ja)
*
|
1995-02-24 |
2010-06-16 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子分散体を含有するエアロゾル
|
|
US5643552A
(en)
*
|
1995-03-09 |
1997-07-01 |
Nanosystems L.L.C. |
Nanoparticulate diagnostic mixed carbonic anhydrides as x-ray contrast agents for blood pool and lymphatic system imaging
|
|
US5521218A
(en)
*
|
1995-05-15 |
1996-05-28 |
Nanosystems L.L.C. |
Nanoparticulate iodipamide derivatives for use as x-ray contrast agents
|
|
US5635406A
(en)
*
|
1995-06-07 |
1997-06-03 |
Abbott Laboratories |
Stabilized standards and calibrators containing rapamycin and tacrolimus bound to anti-rapamycin and anti-tacrolimus antibodies
|
|
US5985890A
(en)
*
|
1995-06-09 |
1999-11-16 |
Novartis Ag |
Rapamycin derivatives
|
|
GB9515214D0
(en)
*
|
1995-07-25 |
1995-09-20 |
Univ Strathclyde |
Plant extracts
|
|
US5962019A
(en)
*
|
1995-08-25 |
1999-10-05 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
|
US5631741A
(en)
*
|
1995-12-29 |
1997-05-20 |
Intel Corporation |
Electronic carbon paper
|
|
JP4163254B2
(ja)
*
|
1996-01-03 |
2008-10-08 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
ムチリンのカルバモイルオキシ誘導体および抗細菌剤としてのそれらの使用
|
|
US5744460A
(en)
*
|
1996-03-07 |
1998-04-28 |
Novartis Corporation |
Combination for treatment of proliferative diseases
|
|
US5637625A
(en)
*
|
1996-03-19 |
1997-06-10 |
Research Triangle Pharmaceuticals Ltd. |
Propofol microdroplet formulations
|
|
PT956034E
(pt)
*
|
1996-07-30 |
2002-12-31 |
Novartis Ag |
Composicoes farmaceuticas para o tratamento da rejeicao de transplantes estados inflamatorios ou auto-imunes compreendendo ciclosporina a e 40-o-(2-hidroxietil)-rapamicina
|
|
WO1998007414A1
(en)
*
|
1996-08-22 |
1998-02-26 |
Research Triangle Pharmaceuticals Ltd. |
Compositions comprising microparticles of water-insoluble substances and method for preparing same
|
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6051563A
(en)
*
|
1997-02-12 |
2000-04-18 |
U.S. Bioscience, Inc. |
Methods for the administration of amifostine and related compounds
|
|
WO1998035666A1
(en)
*
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
|
US6045829A
(en)
*
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
|
US5989591A
(en)
*
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
JP2002505318A
(ja)
*
|
1998-03-05 |
2002-02-19 |
アゴーロン・ファーマシューティカルズ・インコーポレイテッド |
非ペプチドＧｎＲＨ因子
|
|
ATE318132T1
(de)
*
|
1998-03-30 |
2006-03-15 |
Jagotec Ag |
Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung
|
|
US6228985B1
(en)
*
|
1998-05-21 |
2001-05-08 |
Schering Corporation |
Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents
|
|
US5962536A
(en)
*
|
1998-07-31 |
1999-10-05 |
Komer; Gene |
Injectable propofol formulations
|
|
US6028108A
(en)
*
|
1998-10-22 |
2000-02-22 |
America Home Products Corporation |
Propofol composition comprising pentetate
|
|
US6140373A
(en)
*
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
|
US6225311B1
(en)
*
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6200085B1
(en)
*
|
1999-03-08 |
2001-03-13 |
Stuart Gee |
Transport system for farm combines and other large vehicles
|
|
US6267989B1
(en)
*
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
|
US6177477B1
(en)
*
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6100302A
(en)
*
|
1999-04-05 |
2000-08-08 |
Baxter International Inc. |
Propofol formulation with enhanced microbial characteristics
|
|
US6362234B1
(en)
*
|
2000-08-15 |
2002-03-26 |
Vyrex Corporation |
Water-soluble prodrugs of propofol for treatment of migrane
|
|
US6399087B1
(en)
*
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
WO2003080027A1
(en)
*
|
2002-03-20 |
2003-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
CN101106972A
(zh)
*
|
2004-11-16 |
2008-01-16 |
伊兰制药国际有限公司 |
注射用纳米微粒奥氮平制剂
|
|
SE530813C2
(sv)
*
|
2007-01-31 |
2008-09-16 |
Tolerans Ab |
Förfarande och anordning vid en rotationshäftmaskin
|